EICHORCondition: Breast Cancer · Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which patients are most likely to respond to the combination of trastuzumab and pertuzumab when given prior to surgery.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama Comprehensive Cancer Center | Birmingham, Alabama, United States | — |
| Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital | Washington D.C., District of Columbia, United States | — |
| Indiana University Simon Cancer Center | Indianapolis, Indiana, United States | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore, Maryland, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| Lineberger Comprehensive Cancer Center | Chapel Hill, North Carolina, United States | — |
| Vanderbilt University | Nashville, Tennessee, United States | — |
| Baylor College of Medicine | Houston, Texas, United States | — |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | — |
| Fred Hutchinson Cancer Research Center - University of Washington | Seattle, Washington, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01937117